Bill > HB2427

This bill amends Pennsylvania's insurance law to improve access to treatments for stage four, advanced metastatic cancer, which is defined as cancer that has spread to nearby tissues, lymph nodes, or other parts of the body. Specifically, it prohibits insurers from requiring patients to try and fail other treatments before covering approved drugs for this advanced cancer stage, provided the drug is approved by the U.S. Food and Drug Administration (FDA) for the condition and its use aligns with current best clinical practices and peer-reviewed medical literature. The bill also repeals the "Fair Access to Cancer Treatment Law" from 2020, stating that the new provisions are a continuation of that law's intent and that existing actions and agreements under the repealed law will remain in effect.